NISSEN TORBEN STRAIGHT 4
4 · Rubius Therapeutics, Inc. · Filed Jul 26, 2019
Insider Transaction Report
Form 4
NISSEN TORBEN STRAIGHT
President
Transactions
- Exercise/Conversion
Common Stock
2019-07-24$0.19/sh+32,146$6,108→ 2,052,450 total - Exercise/Conversion
Common Stock
2019-07-24$0.18/sh+175,000$31,500→ 2,020,304 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-07-24−175,000→ 175,000 totalExercise: $0.18Exp: 2026-11-28→ Common Stock (175,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-07-24−32,146→ 82,854 totalExercise: $0.19Exp: 2027-04-02→ Common Stock (32,146 underlying)
Footnotes (2)
- [F1]The option, representing a right to purchase a total of 350,000 shares, 87,500 of which became exercisable on July 17, 2019 and 87,500 of which became exercisable on July 24, 2019.
- [F2]The option, representing a right to purchase a total of 115,000 shares, 28,750 of which became exercisable on July 17, 2019 and 3,396 of which became exercisable on July 24, 2019.